Low density of ghrelin cells in the oxyntic mucosa correlated to slow gastric emptying in patients with type 1 diabetes

Molecular Medicine Reports

Volumn 2, Issue 6, 2009, Pages 893-896

  El Salhy, M ^a,b   Rauma, J ^b  

^a UNIVERSITY OF BERGEN   (Norway)

^b Department of Medicine   (Norway)

Author keywords

Diabetes; Gastric emptying; Ghrelin; Oxyntic mucosa

Indexed keywords

GHRELIN; GLUCOSE;

ADULT; AGED; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DUODENUM; FEMALE; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PATHOPHYSIOLOGY; PROTEIN FUNCTION; STOMACH MUCOSA; STOMACH PARESIS; STOMACH SCINTISCANNING;

RODENTIA;

EID: 70350761650     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000188     Document Type: Article

References (23)

1. Kojima M, Hosoda H, Date J, Nakazato M, Matsuo H and Kangawa K: Ghrelin is growth-hormone-releasing acetylated peptide from stomach. Nature 402: 656-660, 1999.
2. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K and Nakazato M: Ghrelin, a novel growth hormone-releasing acetylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141: 4255-4261, 2000.
3. Hataya Y, Akamizu T, Takaya K, Ariyasu N, Sajo M, Moriyama K, Shimatsu A, Kojima M, Kangawa K and Nakato K: A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 86: 4552-4555, 2001.
4. Ghatei MA and Bloom SR: Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86: 5992-5995, 2000.
5. Wren AM, Seal LJ, Cohen MA, Brynes A, Frost GS, Murphy KG, Dhillo LO and Chatei MA: Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86: 5992-5995, 2001.
6. Hosoda H, Kojima M and Kangawa K: Ghrelin and the regulation of food intake and energy balance. Mol Interv 8: 494-503, 2002.
7. Cowley MA and Grove KL: Ghrelin - satisfying a hunger for the mechanism. Endocrinology 145: 2604-2606, 2004.
8. Fujino K, Inui A, Asakawa A, Kihara N, Fujimura M and Fujimiya M: Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol 550: 227-240, 2003.
9. Masuda Y, Tanaka T, Inomata N, Ohmura N, Tanaka S, Itoh Z, Hosisa H, Kojima M and Kangawa K: Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 276: 905-908, 2000.
10. El-Salhy M: The possible role of the gut neuroendocrine system in diabetes gastroenteropathy. Histol Histopathol 4: 1153-1161, 2002.
11. El-Salhy M: Gut neuroendocrine system in diabetes gastroenteropathy: possible role in pathophysiology and clinical implications. In: Focus on Diabetes Mellitus Research. Ashley M. Ford (ed). Nova Science Publishers Inc., New York, pp79-102, 2006.
12. Koch KL: Diabetic gastropathy. Gastric neuromuscular dysfunction in diabetes mellitus. A review of symptoms, pathophysiology and treatment. Dig Dis Sci 44: 1061-1075, 1999.
13. El-Salhy M and Sitohy B: Abnormal gastrointestinal endocrine cells in patients with diabetes type 1: relation to gastric emptying and myoelectrical activity. Scand J Gastroenterol 36: 1162-1169, 2001.
14. El-Salhy M, Stenling R and Grimelius L: Peptidergic innervation and endocrine cells in the human liver. Scand J Gastroenterol 28: 809-815, 1993.
15. El-Salhy M, Sandström O, Näsström E, Mustajbasic M and Zachrisson S: Application of computer image analysis in endocrine cell quantification. J Histochem 29: 249-255, 1997.
16. Masaoka T, Suzuki H, Hosoda H, Ota T, Minegishi Y, Nagata H, Kangawa K and Ishii H: Enhanced plasma ghrelin levels in rats with streptozotocin-induced diabetes. FEBS Lett 541: 64-68, 2003.
17. Rauma J, Spångéus A and El-Salhy M: Ghrelin cell density in the gastrointestinal tracts of animal models of type 1 and type 2 diabetes. Histol Histopathol 21: 1-5, 2006.
18. Binn M, Albert C, Gougeon A, Maereki H, Coulie B, Lemoyne M, Rabasa-Lhoret R, Tomasetto C and Poitras P: Ghrelin gastrokinetic action in patients with neurogenic gastroparesis. Peptides 27: 1603-1606, 2006.
19. Murray CDR, Martin NM, Patterson M, Taylor SA, Ghatei MA, Kamm MA, Johnston C, Bloom SR and Emmanuel AV: Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 54: 1693-1698, 2005.
20. Katuski A, Urakawa H and Gabazza EC: Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinaemia and insulin resistance in patients with type 2 diabetes mellitus. Euro J Endocrionol 151: 573-577, 2004.
21. Del Rincon JP, Thorner MO and Gaylinn BD: Motilin-related peptide and ghrelin: lessons from molecular techniques, peptide chemistry and receptor biology. Gastroenterology 120: 588-589, 2001.
22. Folwaczny C, Chang JK and Tschöp M: Ghrelin and motilin: two sides of one coin? Euro J Endocrinol 144: 1-3, 2001.
23. Tomasetto C, Karam SM, Ribieras S, Masson R, Lefebvr O, Staub A, Alexander G, Chenard MP and Rio MC: Identification and characterization of novel gastric peptide hormone: the motilin-related peptide. Gastroenterology 119: 395-405, 2000.